idarubicinol has been researched along with Ph 1 Chromosome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audhuy, B; Baranger, L; Béné, MC; Berthou, C; Blanchet, O; Cahn, JY; Caillot, D; Casassus, P; Delain, M; Garidi, R; Guyotat, D; Harousseau, JL; Hunault, M; Ifrah, N; Jouet, JP; Lamy, T; Lioure, B; Pignon, B; Sadoun, A; Solal-Celigny, P; Sotto, JJ; Stalnikiewicz, L; Truchan-Graczyk, M; Witz, F | 1 |
1 trial(s) available for idarubicinol and Ph 1 Chromosome
| Article | Year |
|---|---|
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Daunorubicin; Humans; Interferon-alpha; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Transplantation, Homologous; Treatment Outcome; Vincristine | 2004 |